期刊文献+

我国儿童急需但缺乏的基本药物剂型和规格的遴选 被引量:6

The Selection of Dosage Forms and Specifications of Essential Medicines in Urgent Need and Deficient for Chinese Children
原文传递
导出
摘要 目的遴选儿童用基本药物国外已上市但国内缺乏、儿童适宜且临床急需的剂型、规格。方法依据国内外现存的权威文件,结合专家咨询法,自拟儿童用基本药物品种、适宜剂型、适宜规格遴选标准,临床需求类型分类、需求程度分级标准,分类分级遴选。结果遴选出儿童用基本药物国外上市但国内缺乏、儿童适宜且临床急需的剂型、规格清单,含药物品种61个、剂型20个、规格112个,112个品规包括Ⅰ级需求(即十分急需)0个,Ⅱ级需求(即急需)27个,Ⅲ级需求(即一般急需)85个。结论可将27个Ⅱ级需求药物品规纳入我国儿童药物申报审评专门通道。 Objective To build the list of appropriate dosage forms and specifications of essential medicines for children which is subsistent abroad and absent in China. Methods Based on the authoritative data and expert consultation, we established the selection methodology which included the standard of essential medicine for children, the standard of appropriate dosage for children, the standard of appropriate specifications for children, the standard of urgent classification, the standard of urgent level. Results The list of appropriate dosage forms and specifications included 61 medicines which included 20 dosage forms and 112 specifications. 112 specifications included 27 specifications which belong to level II, and 85 specifications which belong to level III. Conclusion The established list can be included by the green channel.
出处 《中国循证医学杂志》 CSCD 2016年第5期497-504,共8页 Chinese Journal of Evidence-based Medicine
基金 国家自然科学基金(编号:81373381) 国家卫生计生委药物政策与基本药物制度司2014年委托课题
关键词 基本药物 儿童 剂型 规格 循证遴选 Essential drugs Child Dosage forms Specification Evidence-based selection
  • 相关文献

参考文献12

  • 1国家卫生计生委药物政策与基本药物制度司.关于保障儿童用药的若干意见.Available at: http://www.nhfpc.gov.cn/yaozs/s3581/201405/e51354d631944fa68aac0c4d9585f291.shtml.
  • 2国家卫生计生委药物政策与基本药物制度司.《国家基本药物目录》(2012年版)(卫生部令第93号).cchttp.V/www.nhfpc.gov.cn/yaozs/s3580/201303/87a46f5a3b6f46908b5cal8102581533.shtml.
  • 3WHO. WHO Model List of Essential Medicines for Children (April2013). Available at: http://www.who.int/medicines/publications/essentialmedicines/en/index.html.
  • 4胡仪吉,金有豫主编.中国国家处方集(化学药品与生物制品卷)(儿童版).第1版.北京:人民军医出版社,2013.
  • 5WHO. WHO Expert Committee on Specifications forPharmaceutical Preparations (TRS 970 - Forty-sixth report).
  • 6vailable at: http://www.who.int/medicines/areas/quality_safety/quality_assurance/expert_committee/trs__970/en/.
  • 7European Medicine Agency. Committee for Medicinal Productsfor Human Use. Reflection paper: formulations of choice for thepaediatric population. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500003782&mid=WC0b01ac058009a3dc.
  • 8中华人民共和国国家卫生和计划生育委员会.2013年中国卫生统计年鉴.http://www.nhfpc.gov.cn/htmlfiles/zwgkzt/ptjnj/year2013/index2013.html.
  • 9刘丹,程静,张伶俐,李幼平,曾力楠,张川.WHO、印度、南非儿童基本药物目录与中国2012版基本药物目录的比较研究[J].中国循证医学杂志,2015,15(4):393-402. 被引量:8
  • 10WHO. Essential medicines. Available at: http://www.who.int/topics/essential__medicines/en/.

二级参考文献22

  • 1WHO. Essential medicine. Available at: http: //www.who.int/medicines/services/essmedicines_def/en/.
  • 2WHO. WHO Model List of Essential Medicines for Children 4th list (April 2013) Available at: http://www.who.int/medicines/publications/essentialmedicines/4th_EMLc_FINAL_web_8Jul13.pdf.
  • 3Indian Academy of Pediatrics. Indian Academy of Pediatrics List of Essential Medicines for Children of India First List - October 2011. Available at: http://www.iapindia.org/files/IAP%20EMLc%20October%2031.pdf.
  • 4The National Department of Health, Pretoria, South Africa. Standard treatment guidelines and essential drugs list for South Africa hospital level paediatrics 2006edition. Available at: http:// www.kznhealth.gov.za/chrp/documents/Guidelines/Guidelines%20National/EDL%20Paediatrics/EDL%20Paediatrics%20Hospital%20Level%202006.pdf.
  • 5胡仪吉, 金有豫, 主编. 第1版. 中国国家处方集(化学药品与生物制品卷·儿童版). 北京: 人民军医出版社, 2013.
  • 6WHO. South Africa Statistics. Available at: http://www.who.int/countries/zaf/en/.
  • 7WHO. India Statistics. Available at: http://www.who.int/countries/ind/en/.
  • 8WHO. China Statistics. Available at: http://www.who.int/countries/chn/zh/index. Html.
  • 9GBD. Global Burden of Disease Study 2010- China Results by Cause 1990-2010. Available at: http://ghdx.healthmetricsandevaluation.org/global-burden-disease-study-2010-gbd-2010-data-downloads.
  • 10GBD. Global Burden of Disease Study 2010- India Results by Cause 1990-2010. Available at: http://ghdx.healthmetricsandevaluation.org/global-burden-disease-study-2010-gbd-2010-data-downloads.

共引文献10

同被引文献72

  • 1陈运彬,张小庄,帅春,杨杰,汪灏,吴婕翎,朱东生,罗爱明,杨琳琳,叶秀桢,向建文,高薇薇.区域性危重新生儿转运系统运作10年的远期效果随访[J].中国妇幼保健,2005,20(8):908-910. 被引量:17
  • 2丁英儿,张东萍,毛敏莉.对掰分药片重量差异及微生物污染的考察[J].中国药房,2005,16(19):1511-1512. 被引量:18
  • 3谢云芬,姚卓贤,谢建芬.口服片剂分劈重量差异性的研究[J].海峡药学,2007,19(5):14-16. 被引量:8
  • 4药物政策与基本药物制度司.2012年版《国家基本药物目录》发布.Available from:http://www.moh.gov.cn/mohywzc/s3582/201303/b058a4edf14e4dc9a1f6f0f0c71a2cce.shtml.
  • 5World Health Assembly. Resolution WHA 28.66. Geneva: World Health Organization, 1975.
  • 6WHO. WHO Model Lists of Essential Medicines. Available at: http://www.who.int/medicines/publications/essentialmedicines/cn/.
  • 7WHO. WHO Policy Perspectives on Medicines - The Selection of Essential Medicines. 2002.
  • 8WalidBinHosain.孟加拉国及其他国家基本药物政策对中国的启示.复旦大学,2009.
  • 9徐文娟.我国基本药物目录及其实施现况.复旦大学,2012.
  • 10国家卫生和计划生育委员会.关于保障儿童用药的若干意见.Availableat:http://www.mohrss.gov.cn/SYrlzyhshbzb/1dbk/shehuibaozhang/yiliao/201406/t20140605-131493.htm.

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部